PIXYL develops AI-powered software designed to analyze brain MRI scans for neurological assessment and care. The company’s platform applies automated algorithms to detect brain lesions and quantify structural changes with clinical precision. Its tools are cleared for clinical use and are intended to support radiologists and neurologists in routine practice. PIXYL positions its technology within regulated medical imaging and neurological care workflows.

The technology processes standard brain MRI sequences using machine learning models trained to identify and segment lesions and anatomical structures. Automated volumetric analysis enables consistent measurement of brain regions and pathological changes over time. These outputs support objective assessment while reducing variability associated with manual interpretation. The system is designed to integrate seamlessly into existing radiology infrastructure.

PIXYL targets neurological conditions where accurate imaging assessment is critical, including multiple sclerosis and other disorders involving structural brain changes. The platform is intended to support diagnosis, monitoring, and treatment evaluation within clinical settings. Its focus reflects broader adoption of AI-driven imaging tools that enhance efficiency, consistency, and quantitative insight in neurological care.